Showing stories 1 - 2 of about 2
Array Biopharma ANNOUNCES Trial Endpoint Met and 4 Stocks Achieving 52 ...
Amylin Pharmaceutica (NASDAQ:AMLN): Adage Capital reports a 5.2 percent passive stake in Amylin. The shares closed at $30.79, down $0.02 or 0.06% on the day.
Related articles »
UPDATE: BWS Financial Drops Coverage of Dorman Products
BWS Financial dropped its Sell rating on Dorman Products (NASDAQ: DORM) following second quarter results from the company. BWS Financial commented, "DORM was able to achieve a slight sequential increase in revenue even though much of the ...